Skip to main content

Advertisement

Avoidable Deaths from Smoking: A Global Perspective

Public Health Reviewsvolume 33, pages569–600 (2011) | Download Citation

Article metrics

  • 2290 Accesses

  • 17 Citations

Abstract

On current consumption patterns, about 400 million adults worldwide will be killed by smoking between 2010 and 2050. Most of these deaths will occur among smokers currently alive. At least half will die at ages 30–69 years, losing decades of productive life. Smoking-attributable mortality has fallen sharply in high-income countries but will rise globally unless today’s smokers, most of whom live in low- and middle-income countries, quit smoking before or during middle age. The single most important intervention to raise cessation rates is a large increase in taxes. Tripling excise taxes on tobacco would raise cessation rates and deter smoking initiation. Higher taxes, regulations on smoking and information for consumers could avoid at least 115 million smoking deaths in the next few decades, including at least 25 million cancer deaths and 50 million vascular deaths.

References

  1. 1.

    Jha P, Chaloupka FJ, Moore J, Gajalakshmi V, Gupta PC, Peck R, et al. Tobacco addiction. In: Disease Control Priorities in Developing Countries. Jamison DT, Breman JG, Measham AR, et al., (editors). New York, NY: Oxford University Press; 1996. p.869–86.

  2. 2.

    Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13:388–95.

  3. 3.

    Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005;116:963–71.

  4. 4.

    World Health Organization. MPOWER: A Policy Package to Reverse the Tobacco Epidemic. Geneva: WHO; 2011.

  5. 5.

    Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer. 2009;9:655–64.

  6. 6.

    Peto R, Lopez AD. The future worldwide health effects of current smoking patterns. In: Critical Issues in Global Health. Koop EC, Pearson CE, Schwarz MR, (editors). New York, NY; Jossey-Bass: 2001.

  7. 7.

    World Health Organization. Tobacco or health: a Global Status Report. Geneva: WHO; 1997.

  8. 8.

    International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans. Vol. 83: Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC; 2004.

  9. 9.

    US Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General. Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989.

  10. 10.

    International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans. Vol. 89: Smokeless Tobacco and Some Tobacco-Specific n-Nitrosamines. Lyon, France: IARC; 2007.

  11. 11.

    US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: US DHHS, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000.

  12. 12.

    US Department of Health and Human Services. Health Consequences of Involuntary Exposure to Tobacco Smoke. US DHHS; 2006.

  13. 13.

    United Nations. World Population Prospects: the 2010 Revision. Updated 20 October 2011. Available from URL: http://esa.un.org//unpd/wpp/index.htm (accessed 31 August 2012).

  14. 14.

    World Health Organization, Country Office for Bangladesh. Global Adult Tobacco Survey: Bangladesh Report 2009. Bangladesh: WHO; 2009. Available from URL: http://www.who.int/tobacco/surveillance/gats_bangladesh/en/index.html (accessed 31 August 2012).

  15. 15.

    Instituto Nacional de Câncer (Brasil). Global Adult Tobacco Survey Brazil Report 2008. Rio de Janeiro: INCA; 2010. Available from URL: http://www.who.int/tobacco/surveillance/en_tfi_gats_2010_brazil.pdf (accessed 31 August 2012).

  16. 16.

    GATS China. Global Adult Tobacco Survey. Fact Sheet China: 2010. Available from URL: http://www.who.int/tobacco/surveillance/gats_china/en/index.html (accessed 31 August 2012).

  17. 17.

    Central Agency for Public Mobilization and Statistics. Ministry of Health, Egypt. Global Adult Tobacco Survey (GATS) Egypt Country Report 2009. World Health Organization; 2010. Available from URL: http://www.who.int/tobacco/surveillance/gats_egypt/en/index.html (accessed 31 August 2012).

  18. 18.

    International Institute for Population Sciences, Ministry of Health and Family Welfare, Government of India. Global Adult Tobacco Survey India (GATS) India Report 2009–2010. World Health Organization; 2010. Available from URL: http://www.whoindia.org/en/Section20/Section25_1861.htm (accessed 31 August 2012).

  19. 19.

    Ministry of Health, Mexico. Encuesta Global de Tabaquismo en Adultos, México 2009. Washington, DC: Pan American Health Organization; 2010. Available from URL: http://www.who.int/tobacco/surveillance/gats_rep_mexico.pdf (accessed 31 August 2012). [In Spanish].

  20. 20.

    GATS Philippines. Philippines Global Adult Tobacco Survey Country Report 2010. Available from URL: http://www.who.int/tobacco/surveillance/gats_philippines/en/index.html (accessed 31 August 2012).

  21. 21.

    Ministry of Health, Poland. Global Adult Tobacco Survey Poland 2009–2010. Ministry of Health, Poland; 2010. Available from URL: http://www.who.int/tobacco/surveillance/en_tfi_gats_poland_report_2010.pdf (accessed 31 August 2012).

  22. 22.

    GATS Russian Federation. Global Adult Tobacco Survey Russian Federation 2009. Available from URL: http://www.who.int/tobacco/surveillance/en_tfi_gats_russian_countryreport.pdf (accessed 31 August 2012).

  23. 23.

    World Health Organization, Regional office for South East Asia. Global Adult Tobacco Survey: Thailand Country Report. Thailand: WHO; 2009. Available from URL: http://www.who.int/tobacco/surveillance/thailand_gats_report_2009.pdf (accessed 31 August 2012).

  24. 24.

    The Ministry of Health of Turkey. Global Adult Tobacco Survey Turkey Report 2010. Turkey: Ministry of Health; 2010. Available from URL: http://www.havanikoru.org.tr/Docs_Tutun_Dumaninin_Zararlari/GATS.pdf (accessed 31 August 2012).

  25. 25.

    GATS Ukraine. Global Adult Tobacco Survey (GATS) Report Ukraine 2010. Ukraine: 2010. Available from URL: http://www.who.int/tobacco/surveillance/en_tfi_gats_ukraine_report_2010.pdf (accessed 31 August 2012).

  26. 26.

    GATS Uruguay. Global Adult Tobacco Survey Uruguay (GATS) Fact Sheet Uruguay 2009. February 2010. Available from URL: http://www.who.int/tobacco/surveillance/gats_uruguay/en/index.html (accessed 31 August 2012).

  27. 27.

    Ministry of Health Of Viet Nam, Hanoi Medical University, General Statistics Office, Centers for Disease Control and Prevention, World Health Organization. Global Adult Tobacco Survey (GATS) Viet Nam 2010. Hanoi: 2010. Available from URL: http://www.who.int/tobacco/surveillance/en_tfi_gats_vietnam_report.pdf (accessed 31 August 2012).

  28. 28.

    Warren CW, Jones NR, Eriksen MP, Asma S; Global Tobacco Surveillance System (GTSS) collaborative group. Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet. 2006;367:749–53.

  29. 29.

    International Smoking Statistics. A Collection of Historical Data from 30 Economically Developed Countries. Forey B, Hamling J, Lee P, (editors). New York, NY: Oxford University Press; 2009.

  30. 30.

    Jha P, Guindon E, Joseph RA, Nandi A, John RM, Rao K, et al. A rational taxation system of bidis and cigarettes to reduce smoking deaths in India. Econ Polit Wkly. 2011;46:44–51.

  31. 31.

    Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989–2003). Bull World Health Organ. 2007;85:527–34.

  32. 32.

    Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health. 2002;92:1002–6.

  33. 33.

    Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321:323–9.

  34. 34.

    Chinese Academy of Preventive Medicine, Smoking in China: 1996 National Prevalence Survey of Smoking Pattern. Beijing: Science and Technology Press; 1997.

  35. 35.

    Jenkins CN, Dai PX, Ngoc DH, Kinh HV, Hoang TT, et al. Tobacco use in Vietnam. Prevalence, predictors, and the role of the transnational tobacco corporations. JAMA. 1997;277:1726–31.

  36. 36.

    Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, et al. A nationally representative case-control study of smoking and death in India. N Engl J Med. 2008;358:1137–47.

  37. 37.

    Sample Registration System Baseline Survey Report, 2004. New Delhi: Registrar General of India; 2007.

  38. 38.

    The hazards of smoking and the benefits of stopping. In: IARC Handbooks of Cancer Prevention. Tobacco control. Vol. 11: Reversal of risk after quitting smoking. Dresler C, Leon M, (editors). Lyon: International Agency for Research on Cancer; 2007. p.15–27.

  39. 39.

    Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191–308.

  40. 40.

    Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519.

  41. 41.

    Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ. 1994;309:901–11.

  42. 42.

    Thun, MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene. 2002;21:7307–25.

  43. 43.

    Peto R, Lopez AD, Boreham J, Thun M. Mortality from Smoking in Developed Countries, 1950–2000. 3rd ed. 2009.

  44. 44.

    Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992;339:1268–78.

  45. 45.

    Peto R, Lopez AD, Boreham J, Thun M and Heath Jr C. Mortality from Smoking in Developed Countries, 1950–2000. Oxford: Oxford University Press; 1994.

  46. 46.

    Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ. 1998;317:1411–22.

  47. 47.

    Niu SR, Yang GH, Chen ZM, Wang JL, Wang GH, He XZ, et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ. 1998;317:1423–4.

  48. 48.

    Zatonski W, Jha P. The Health Transformation in Eastern Europe after 1990: A Second Look. Warsaw: Marie Skeodowska-Curie Cancer Center and Institute of Oncology; 2000.

  49. 49.

    Crispo A, Brennan P, Jöckel KH, Schaffrath-Rosario A, Wichmann HE, Nyberg F, et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer. 2004;91:1280–6.

  50. 50.

    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. The Global Burden of Disease and Risk Factors. Washington, DC, and New York, NY: World Bank and Oxford University Press; 2006.

  51. 51.

    Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, et al. Mortality attributable to smoking in China. N Engl J Med. 2009;360:150–9.

  52. 52.

    Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al. Cancer mortality in India: a nationally representative mortality survey. Lancet. 2012;379:1807–16.

  53. 53.

    Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control. 2003;14:805–14.

  54. 54.

    Jha P, et al. Evidence-based Cardiology. Yusuf S, et al., (editors). Oxford: Oxford University Press; 2009.

  55. 55.

    Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial intraction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647–58.

  56. 56.

    Smith KR, Mehta S. The burden of disease from indoor air pollution in developing countries: comparison of estimates. Int J Hyg Environ Health. 2003;206:279–89.

  57. 57.

    Doll R, Hill AB. Mortality in relation to smoking: ten years’ observations of British doctors. Br Med J. 1964;1:1460–7 CONCL.

  58. 58.

    Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol. 2005;34:1395–402.

  59. 59.

    Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet. 2003;362:507–15.

  60. 60.

    Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA. 2000;284:706–12.

  61. 61.

    Rostron B. Smoking-attributable mortality in the United States. Epidemiology. 2011;22:350–5.

  62. 62.

    Jha P, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet. 2006;368:367–70.

  63. 63.

    Peto R, Whitlock G, Jha P. Effects of Obesity and Smoking on U.S. Life Expectancy N Engl J Med. 2010;362:855–7.

  64. 64.

    Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96

  65. 65.

    Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28:w822–31.

  66. 66.

    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.

  67. 67.

    The Economist. Tobacco and tolerance. 20 December 1997. p.59–61.

  68. 68.

    Jha P, Chaloupka FJ. Curbing the Epidemic: Governments and the Economics of Tobacco Control. Washington DC: World Bank; 1999.

  69. 69.

    Jha P, Chaloupka FJ. Tobacco Control in Developing Countries. Oxford: Oxford University Press; 2000.

  70. 70.

    Jha P, Musgrove P, Chaloupka FJ, Yurkeli A. The Economic rationale for intervention in the tobacco market. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, ( editors ). Oxford and New York, NY: Oxford University Press; 2000. p.153–74.

  71. 71.

    US Department of Health and Human Services. The health consequences of smoking: the changing cigarette. A report of the Surgeon General. Washington, DC: US DHHS, Centers for Disease Control and Prevention; 2001.

  72. 72.

    Lightwood J, Collins D, Lapsley H, et al. Estimating the costs of tobacco use. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  73. 73.

    John RM, Sung HY, Max W. Economics cost of tobacco use in India, 2004. Tob Control. 2009;18:138–43.

  74. 74.

    Little International Inc. Public finance balance of smoking in the Czech Republic. 2000. URL: http://tobaccofreekids.org/reports/philipmorris/pmczechstudy.pdf (viewed 5 July 2011).

  75. 75.

    John RM, Sung HY, Max WB, Ross H. Counting 15 million more poor in India, thanks to tobacco. Tob Control. 201;20:349–52.

  76. 76.

    Rani M, Bonu S, Jha P, Nguyen SN, Jamjoum L. Tobacco use in India: prevalence and predictors of smoking and chewing in a national cross sectional household survey. Tob Control. 2003;12:e4.

  77. 77.

    John RM. Crowding out effect of tobacco expenditure and its implications on household resource allocation in India. Soc Sci Med. 2008;66:1356–67.

  78. 78.

    Peck R, et al. An analyes of the economic welfare from tobacco use. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000. p.211–21.

  79. 79.

    Gruber J, Mullainathan S. Do cigarette taxes make smokers happy? Adv Econ Anal Pol. 2005;5:Article 4.

  80. 80.

    Hamilton WL, Biener L, Rodger CN. Who supports tobacco excise taxes? Factors associated with town’s and individual’s support in Massachusetts. J Public Health Manag Pract. 2005;11:333–40.

  81. 81.

    Hill C, Jougla E, Beck F. Prévention et facteurs de risque. Institut de cancérologie Gustave Roussy. 2010. Available from URL: http://www.igr.fr/fr/page/prevention-et-facteurs-de-risque_80 (accessed 3 September 2012). [In French]

  82. 82.

    Harris JE, Thun MJ, Mondul AM, Calle EE. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982–8. BMJ. 2004;328:72.

  83. 83.

    Chaloupka FJ, Tauras JA, Grossman M. The economics of addiction. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  84. 84.

    Chaloupka FJ, Warner KE. The economics of smoking. In: The Handbook of Health Economics. Newhouse J, Culyer A, (editors). Amsterdam: Elsevier Science; 2000.

  85. 85.

    Chaloupka FJ, et al. The taxation of tobacco products. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  86. 86.

    Van Walbeek C. Tobacco control in South Africa. Promot Educ. 2005;Suppl 4:25–8,57.

  87. 87.

    Wasserman J, Manning WG, Newhouse JP, Winkler JD. The effects of excise taxes and regulations on cigarette smoking. J Health Econ. 1991;10:43–64.

  88. 88.

    Tauras JA, Chaloupka FJ. Impact of tobacco control spending and tobacco control policies on adolescents’ attitudes and beliefs about cigarette smoking. Evidence Based Preventive Medicine. 2004;1:111–20.

  89. 89.

    Tauras JA. The Transition to Smoking Cessation: Evidence from Multiple Failure Duration Analysis: NBER Working Paper No. 7412. Cambridge, MA: National Bureau of Economic Research; 1999.

  90. 90.

    Emery S, White MM, Pierce JP. Does cigarette price influence adolescent experimentation? J Health Econ. 2001;20:261–70.

  91. 91.

    Centers for Disease Control and Prevention (CDC). Response to increases in cigarette prices by race/ethnicity, income, and age groups—United States, 1976–1993. MMWR Morb Mortal Wkly Rep. 1998;47:605–9.

  92. 92.

    Townsend J, Roderick P, Cooper J. Cigarette Smoking by Socio-Economic Group, Sex, and Age: Effects of Price, Income, and Health Publicity. BMJ. 1998;309:923–6.

  93. 93.

    Blecher EH, van Walbeek CP. An international analysis of cigarette affordability. Tob Control. 2004;13:339–46.

  94. 94.

    World Health Organization. WHO Technical Manual on Tobacco Tax Administration. Geneva: WHO; 2010.

  95. 95.

    Recours A. Politique de santé et Fiscalité du tabac. Rapport à Monsieur le Premier Ministre. Septembre 1999. [In French]

  96. 96.

    Guindon E, Bettcher D. Tobacco control in tobacco-producing countries. Bull World Health Organ. 2001;79:1086.

  97. 97.

    IARC Handbooks of Cancer Prevention. Effectiveness of Tax and Price Policies for Tobacco Control, Vol 14. 2011.

  98. 98.

    Eberlee J. South Africa’s Winning Tobacco Control Strategy. The International Development Research Center Reports, 2001.

  99. 99.

    Ciecierski C. Tobacco control and the transitional economies of Europe: aspects of taxation in Poland. In: 12th World Conference on Tobacco OR Health: Global Action for a Tobacco Free Future 2003.

  100. 100.

    Kenkel D, Chen L. Consumer information and tobacco use. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  101. 101.

    Weinstein ND. Accuracy of smokers’ risk perceptions. Ann Behav Med. 1998;20:135–40.

  102. 102.

    UK Medical Research Council. Smoking and Health: Summary and Report of the Royal College of Physicians of London on Smoking in Relation to Cancer of the Lung and Other Diseases. London: UKMRC; 1962.

  103. 103.

    US Department of Health, Education and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control; 1964.

  104. 104.

    Townsend J. Policies to halve smoking deaths. Addiction. 1993;88:37–46.

  105. 105.

    Hammond D, Fong GT, McNeill A, Borland R, Cummings KM. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl 3:iii19–25.

  106. 106.

    McNabola A, Gill LW. The control of environmental tobacco smoke: a policy review. Int J Environ Res Public Health. 2009;6:741–58.

  107. 107.

    Bauer JE, Hyland A, Li Q, Steger C, Cummings KM. A longitudinal assessment of the impact of smoke-free worksite policies on tobacco use. Am J Public Health. 2005;95:1024–9.

  108. 108.

    Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002;325:188.

  109. 109.

    Levy DT, Friend K, Polishchuk E. Effect of clean indoor air laws on smokers: the clean air module of the SimSmoke computer simulation model. Tob Control. 2001;10:345–51.

  110. 110.

    Jacobson PD, Wasserman J. Tobacco Control Laws: Implementation and Enforcement. Santa Monica, CA: RAND; 1997.

  111. 111.

    Cigarette Report for 2004 and 2005. 2007, Washington, D.C.: Federal Trade Commission.

  112. 112.

    Saffer H, Chaloupka FJ. Tobacco advertising: economic theory and international evidence. J Health Econ. 2000;19:1117–37.

  113. 113.

    Blecher E. The impact of tobacco advertising bans on consumption in developing countries J Health Econ. 2008;27:930–42.

  114. 114.

    US Department of Health and Human Services. Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. USDHHS; 1988.

  115. 115.

    Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Mottillo S, Joseph L, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008;179:135–44.

  116. 116.

    Silagy C, et al. Nicotine Replacement Therapy for Smoking Cessation (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software; 2004.

  117. 117.

    West R, Zatonski W, Cedzynska M, Lewandowska D, Pazik J, Aveyard P, Stapleton J. Placebo-Controlled Trial of Cytisine for Smoking Cessation. N Engl J Med. 2011;365:1193–200.

  118. 118.

    Merriman D, Yurekli A, Chaloupka FJ. How big is the worldwide cigarette smuggling problem?, In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  119. 119.

    Joossens L, et al. Issues in the Smuggling of Tobacco Products. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000.

  120. 120.

    Joossens L, Raw M. Turning off the tap: the real solution to cigarette smuggling. Int J Tuberc Lung Dis. 2003;7:214–22.

  121. 121.

    Joossens L, Raw M. Progress in combating cigarette smuggling: controlling the supply chain. Tob Control, 2008;17:399–404.

  122. 122.

    Liberman J. Four COPs and counting: achievements, underachievements and looming challenges in the early life of the WHO FCTC Conference of the Parties. Tob Control. 2012;21:215–20.

  123. 123.

    Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. for the NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47

  124. 124.

    Jha P, Paccaud F, Nguyen S. Strategic priorities in tobacco control for governments and international agencies. In: Tobacco Control in Developing Countries. Jha P, Chaloupka FJ, (editors). Oxford and New York, NY: Oxford University Press; 2000. p. 449–64.

  125. 125.

    Mamudu HM, Hammond R, Glantz S. Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control. Soc Sci Med. 2008;67:1690–9.

  126. 126.

    Jha P, Nugent R, Verguet S, Bloom DE, Hum R. Chronic Diseases. Copenhagen: Consensus Challenge Paper; 2012. Available from URL: http://www.copenhagenconsensus.com/Projects/CC12/Research/ChronicDisease.aspx (accessed 3 September 2012).

  127. 127.

    Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, et al. Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies. PLoS Med. 2008;5:e185.

  128. 128.

    Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a difference disease. Nat Rev Cancer. 2007;7:778–90.

  129. 129.

    Peto R, Beral V. Sir Richard Doll CH OBE. 28 October 1912 — 24 July 2005. Biogr Mems Fell R Soc. 2010;56:63–83. Available from URL: http://rsbm.royalsocietypublishing.org/content/56/63.full.pdf+html (accessed 3 September 2012).

Download references

Author information

Affiliations

  1. Professor Prabhat Jha, Centre for Global Health Research (CGHR), St. Michael’s Hospital, Dalla Lana School of Public Health, University of Toronto, Toronto, M5C 1N8, Canada

    • Prabhat Jha MD, DPhil

Authors

  1. Search for Prabhat Jha MD, DPhil in:

Corresponding author

Correspondence to Prabhat Jha MD, DPhil.

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • Tobacco control
  • global health
  • smoking
  • tobacco deaths
  • low-income countries
  • middle-income countries
  • cessation
  • economics
  • prices
  • information
  • regulation

Public Health Reviews

ISSN: 2107-6952

Contact us